
1.10 Delayed Data As of May 20 | ![]() Today’s Change | 0.88 Today|||52-Week Range 7.72 | -52.79% Year-to-Date |
Aridis Pharmaceuticals (ARDS) Reports Q1 Loss, Lags Revenue Estimates May 16 / Zacks.com - Paid Partner Content |
Previous close | 1.02 |
Today’s open | 1.01 |
Day’s range | 0.95 - 1.10 |
Volume | 270 |
Average volume (3 months) | 1,026,758 |
Market cap | $16.5M |
Earnings growth (last year) | -54.71% |
Earnings growth (this year) | +61.43% |
Earnings growth (next 5 years) | +51.90% |
Revenue growth (last year) | +53.50% |
P/E ratio | NM |
Price/Sales | 18.66 |
Price/Book | -- |
Today’s change | Today’s % change | |
---|---|---|
QLGNQualigen Therapeutic... | -0.00 | -0.63% |
PULMPulmatrix Inc | -0.16 | -3.09% |
---- | ||
--ValiRx PLC | 0.00 | 0.00% |
Next reporting date | August 16, 2022 |
EPS forecast (this quarter) | -$0.48 |
Annual revenue (last year) | $1.5M |
Annual profit (last year) | -$42.2M |
Net profit margin | -2,748.73% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Los Gatos, California |